The most common fusion partner, AFF1 (AF4), followed by MLLT3 (AF9), MLLT1 (ENL), and MLLT10 (AF10), account for a large majority of observed cases of KMT2A-r leukemias (44). Here, KMT2A is linked to leukemia.